paper-with-me

홈 › Papers

A Distributional Robustness Margin For Pathology Foundation Models

2026-07-28 · Clément Grisi, Jeroen van der Laak, Geert Litjens arxiv

Pathology foundation models encode non-biological variation introduced by tissue preparation, staining and scanning, enabling shortcut learning that undermines generalisation across institutions. The Robustness Index (RI) was proposed to assess whether local representation geometry is dominated by biological or non-biological variation. However, its construction suffers from structural limitations that make cross-model comparison unreliable, calling for a more principled metric. We introduce the Cross-confounder Robustness Margin (CRoMa), a signed, per-sample margin that measures whether samples sharing the same biology but different confounder lie closer than samples sharing the same confounder but different biology. It is defined for every sample, allowing models to be compared on the same cohort and robustness to be analysed as a distribution rather than reduced to a single pooled score. We evaluated CRoMa across 20 tile-level encoders on three benchmarks. Rankings by median CRoMa were highly consistent across benchmarks (Spearman rho ~ 0.90), yet every encoder retained confounder-dominated samples, whose prevalence and severity varied markedly. Similar patterns emerged for four slide-level encoders evaluated on a separate benchmark, extending the analysis beyond tile-level representations. Higher median CRoMa was associated with smaller shortcut-induced performance losses in downstream linear probes, supporting its use as a representation-level indicator of shortcut susceptibility.

📄 PDF Abstract BibTeX arXiv:2607.25497

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Atlas 2 -- Foundation models for clinical deployment

2026-01-08 · Maximilian Alber, Timo Milbich, Alexandra Carpen-Amarie, Stephan Tietz 외 arxiv

Pathology foundation models substantially advanced the possibilities in computational pathology -- yet tradeoffs in terms of performance, robustness, and computational requirements remained, which limited their clinical …

Enabling clinical use of foundation models for computational pathology

2026-02-25 · Audun L Henriksen, Ole-Johan Skrede, Lisa van der Schee, Enric Domingo 외 arxiv

Foundation models for computational pathology are expected to facilitate the development of high-performing, generalisable deep learning systems. However, in addition to biologically relevant features, current foundation…

The Good, the Bad, and the Brittle: Benchmarking Robustness and Generalisation of Histopathology Foundation Models

2026-07-05 · Dhyey Yajnik, Amina Asif, Fayyaz Minhas arxiv

How robust and generalisable are pathology foundation models and have their scaling limites been reached? We benchmarked twelve pathology foundation models (PFMs) and ResNet baselines using our Robustness Evaluation and …

UNIStainNet: Foundation-Model-Guided Virtual Staining of H&E to IHC

2026-03-13 · Jillur Rahman Saurav, Thuong Le Hoai Pham, Pritam Mukherjee, Paul Yi 외 arxiv

Virtual immunohistochemistry (IHC) staining from hematoxylin and eosin (H&E) images can accelerate diagnostics by providing preliminary molecular insight directly from routine sections, reducing the need for repeat secti…

Current Pathology Foundation Models are unrobust to Medical Center Differences

2025-01-29 · Edwin D. de Jong, Eric Marcus, Jonas Teuwen

Pathology Foundation Models (FMs) hold great promise for healthcare. Before they can be used in clinical practice, it is essential to ensure they are robust to variations between medical centers. We measure whether patho…

Cancer type classification